Clinical trials
Recruiting Carcinoma, Medullary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| Luo Yaping | 1 |
| Novartis Pharmaceuticals | 1 |
| Shanghai Jiao Tong University School of Medicine | 1 |
| Universidad Nacional Autonoma de Mexico | 1 |
| University of Arizona | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Medullary | 11 |
| Adenoma, Islet Cell | 2 |
| Carcinoma, Merkel Cell | 2 |
| Adrenocortical Carcinoma | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carney Complex | 1 |
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 |
| Esthesioneuroblastoma, Olfactory | 1 |
| Gastrointestinal Stromal Tumors | 1 |
| Glioblastoma | 1 |
Trials
Showing 76 to 11 of 11. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.